LIVE: FDA Holds Workshop on Rare Disease Clinical Investigations

Live News Network
1.4K followers
75 Video Views·Sep 29, 2026
The FDA Rare Disease Innovation Hub and Duke Margolis co-convene a public workshop at 9 a.m. ET on Sept. 29 on statistical considerations in the design, conduct, and analysis of clinical investigations for rare disease medical products.
AI Generated·May contain errors
Video Summary
AI GeneratedThis discussion explores the complexities of designing clinical trials for rare diseases, focusing on the tension between statistical rigor and practical feasibility. Experts emphasize the need for patient-centric, flexible designs—such as Bayesian frameworks and natural history studies—to overcome small sample sizes and high recruitment failure rates while maintaining regulatory integrity.
